BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Aspirin
,
rs2230926
,
MYC
,
Apoptosis
,
Allergy to pollen
,
Lung
,
Personalized medicine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
negative regulation of T cell differentiation in thymus
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Amygdala
Occipital lobe
Trigeminal ganglia
Testes
Parietal lobe
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Tinea pedis
Contact dermatitis
Rhinitis
Infection due to Porphyromonas
Alpha-1-antitrypsin deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Butylhydroxybutylnitrosamine
Mestranol
Nitrazepam
STA 9090
suxibuzone
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Relb
NOP2
HSPA9
DIDO1
ACLY
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Retinoic acid regulation of stage-dependent gene expression in Sertoli cells
L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
The Immunological Genome Project - Immune cell lineage differentiation and maturation
Early stage breast cancer miRNA expression profiles
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for negative regulation of T cell differentiation in thymus
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation
Preconditioning Chemotherapy Combination With Cytokine Induced Killer Cell (CIK) Immunotherapy
Pembrolizumab + Lenalidomide Post Autologous Stem Cell Transplant (ASCT) in High-risk Multiple Myelo…
Cabozantinib and Nivolumab for Carcinoid Tumors
Pembrolizumab in First Line Treatment of Advanced NSCLC Patients With PD-L1 Low Tumors.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ